(Q40648601)

22 September 2017

title

Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations (English)

1 reference

22 September 2017

Variability in Polyene Content and Cellular Toxicity Among Deoxycholate Amphotericin B Formulations (English)

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.5.572.32209

1 January 2024

1 reference

John D. Cleary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12741430

1 January 2024

P. David Rogers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12741430

1 January 2024

Stanley W. Chapman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12741430

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

22 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1592%2Fphco.23.5.572.32209

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.5.572.32209

https://onlinelibrary.wiley.com/doi/full/10.1592/phco.23.5.572.32209

1 January 2024

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.5.572.32209

1 January 2024

1 reference

22 September 2017

volume

23

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

572-578

1 reference

Pretreatment regimens for adverse events related to infusion of amphotericin B.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Amphotericin B induces tumor necrosis factor production by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Amphotericin B activation of human genes encoding for cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Lipid formulations of amphotericin B: clinical efficacy and toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Anaphylaxis upon switching lipid-containing amphotericin B formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.572.32209

Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.5.572.32209

Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

1 January 2024

16

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.5.572.32209

1 January 2024

Identifiers

1 reference

22 September 2017

1 reference